title: Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.
authors.affiliation: BMT Centers of Besançon.
authors.forename: P
authors.initials: P
authors.lastname: Hervé
authors.forename: E
authors.initials: E
authors.lastname: Racadot
authors.forename: J
authors.initials: J
authors.lastname: Wijdenes
authors.forename: M
authors.initials: M
authors.lastname: Flesch
authors.forename: P
authors.initials: P
authors.lastname: Tiberghien
authors.forename: P
authors.initials: P
authors.lastname: Bordigoni
authors.forename: E
authors.initials: E
authors.lastname: Holler
authors.forename: M
authors.initials: M
authors.lastname: Powles
authors.forename: M
authors.initials: M
authors.lastname: Bourdeau
authors.forename: E
authors.initials: E
authors.lastname: Wilmer
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004341:Drug Evaluation; D004351:Drug Resistance; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000276:immunology; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha